記事一覧

分野ごとにこれまでの投稿記事をまとめています。

■一般小児

【Cochrane Corner】乳児の急性細気管支炎に対する高張食塩水吸入のエビデンス(2024/8/4)

"Nebulised Hypertonic Saline Solution for Acute Bronchiolitis in Infants(COCHRANE CORNER)"

Clinical & Experimental Allergy. Aug 2024.54,8:534-537.

【Cochrane】風邪の時のハチミツ内服の有効性(2023/3/31)

"Honey for acute cough in children"

Cochrane Review. 2018, Issue 4.

■アレルギー

＜non-IgE GIFAs＞

-->FPIES

【前向きコホート】ギリシャにおけるAtypical FPIESの特徴(2023/9/2)

"Atypical Food protein-induced enterocolitis syndrome in children:Is IgE sensitization an issue longitudinally?"

Allergol Immunopathol (Madr). 2021 May 1;49(3):73-82.

"Recent Update in Food Protein-Induced Enterocolitis Syndrome: Pathophysiology, Diagnosis, and Management"

Allergy Asthma Immunol Res. 2022;14(6):587-603.

【症例報告】FPIESにおける食物経口負荷試験の修正案(2023/4/8)

"Modified oral food challenge protocol approach in the diagnosis of Food Protein-Induced Enterocolitis Syndrome"

Allergy, Asthma & Clinical Immunology. 2022. 18:8.

【論文/RCT】本邦でのFPIES児の現状(2023/3/24)

"Remission of Acute Food Protein-Induced Enterocolitis Syndrome Confirmed by Oral Food Challenges in Japan."

Nutrients. 2022 Oct 7;14(19):4158.

-->FPIAP

【Review】FPIAPは原因食物を除去するべきか否か？(2024/7/31)

"To Diet or Not to Diet This Is the Question in Food-Protein-Induced Allergic Proctocolitis (FPIAP)—A Comprehensive Review of Current Recommendations"

Nutrients. 2024 Feb 21;16(5):589.

＜食物アレルギー＞

【論文/RCT】アレルギーハイリスク品目を混合したMIXフードによるアレルギー発症予防効果の研究(2023/3/25)

"Early introduction of very small amounts of multiple foods to infants: A randomized trial."

Allergology International. 2022, Jul;71(3):345-353.

＜舌下免疫療法＞

【前向きコホート研究】ダニ感作アレルギー性鼻炎に対する皮下免疫療法と舌下免疫療法の比較(2023/5/8)

"Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study"

Allergol Int. 2023 Mar 12;S1323-8930(23)00011-4.

【観察研究】ダニ舌下免疫療法の早期における有害事象の検討(2023/3/29)

"Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase."

Frontier in Medicine. 2022(9);1-6.

■感染症

【後方視研究】RSウイルス感染に対するLTRAの有用性(2023/4/14)

"Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection"

PLOS ONE. 2022 May 27;17(5):e0269043.

【後方視研究】RSV感染症の児の呼吸・全身状態の評価スコアリング(2023/4/19)

"Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection"

PLOS ONE. 2021 Jul 1;16(7):e0253532.

【事後解析】バロキサビル(ゾフルーザ®)の小児例での安全性と効果(2024/1/8)

"Safety and Efficacy of Baloxavir Marboxil in Influenza-infected Children 5–11 Years of Age: A Post Hoc Analysis of a Phase 3 Study"

Pediatr Infect Dis J. 2023 Nov; 42(11): 983–989.

■呼吸器

【RCT】喘息の急性増悪に対する内服ステロイド：DEX vs PSLの検討(2023/4/24)

"Comparative effectiveness of oral dexamethasone vs. oral prednisolone for acute exacerbation of asthma: A randomized control trial"

J Family Med Prim Care. 2022 Apr; 11(4): 1395–1400.

■消化器

【後方視研究】肥厚性幽門狭窄症に対するアトロピン療法不成功リスク(2023/4/6)

"Risk factors for unsuccessful atropine therapy in hypertrophic pyloric stenosis"

Pediatrics International. 2019 Nov;61(11):1151-1154.